NEW YORK (GenomeWeb) – Thermo Fisher Scientific today reported a 10 percent increase in second quarter revenues, resulting from growth in all of its business segments, in particular analytical instruments.

"We had another excellent quarter," said President and CEO Marc Casper in a conference call this morning to discuss the company's earnings. "Our performance in Q2 contributed to a strong first half and we’re right on track to deliver another great year."

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Microsoft co-founder Paul Allen also contributed to brain research, NPR reports.

The New York Times reports on the shifting interpretations of what some genetic variants mean over time.

In Cell this week: investigation of metastatic tumor evolution, more than 16,000 genetic variants introduced into the budding yeast model organism, and more.

MIT's Technology Review reports on Genentech's pursuit of personalized cancer vaccines.